The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Many who sold or has auto sells will be getting in as and when they see RNS.
Nice buys coming in.
Revenue is up so up the price please. JPM must have some good investors lined up so they dropped the price for them imho. Roll on next week.
of today have any bearing on what is to come?
More than likely the sellers are the so called long term institutional investors cashing in on their IPO shares while they can still make a profit. Most of the trades are type "A" which are mainly institutional sellers.
likely, or those who bought at <550
Wonder who has been selling?
IPO?
and another buy at 591.28p. running out of magic money tree now. :(
topped up a bit more today at 594.07p. I suspect it might touch 590 today but think thats the end of the low cycle, hopefully uptrend next week.
Caught me out topped up yesterday
Hoping for a decent bounce back up.
Added 10,000 shares at 599 /600/601 over a few trades
Like a Yoyo.
Soon will move to 710/720p and then drop back. Happened twice already in short time.
We should finally move towards 800p and repeat process of dropping back to around 750p and up again to 800.
Dropping the price on purpose i am hoping for a quick turnaround. Broker JPM has just recommended £7.80 a shrare.
The Company today announces in respect of the month ended 31 December 2021, the issue of 1,153,813 ordinary shares of £0.0001 each ("Ordinary Shares"), following the exercise of options granted under the Company's share option plans.
Nice finish before Xmas!
Happy Holidays!
Cheers!
Added a lot on dips. Now my largest holding.
Just bought 109 and it shows as a sell !
Oxford Nanopore Technologies's top competitors include Pacific Biosciences of California, Complete Genomics, Illumina and 10X Genomics.
I took advantage of the small drop from over 700p. Looks like overtime we are going to see sp climb nicely.
Good evening.
2 trades gone through time 15:21 for £22million each massive trades. Anyone guess to what went through @6.50?
In the 70`s I secured a post as assistant to a Hoechst director and did my best to be of help, but they let me go at the end of the year, it is a poignant memory as I made my mark elsewhere----but medical terms were beyond my full understanding, as is the information available on this six week old share.
Two things make me invest, knowledgeable sources recommendation, and the chunky SP, which discourages the bane of AIM shares----the day trader who will borrow shares to sell, then borrow to ramp, making plenty where a penny share is involved, but keeping the share price depressed.
You are not alone in asking for informed synopsis of what is on offer [understandable to the non medical]
I am a Dip M, perhaps they sought a marketing viewpoint.
Bought in Nov and topped up on each dip, looking good for strong end of year. Omicron and future variants make this a must have for my portfolio. Interested to hear all views on were ONT will be next year.
to have added on the drop.
Yes x 4 just gone thro.